Managing hyperglycemia during the COVID-19 pandemic: Improving outcomes using new technologies in intensive care

Hyperglycemia is a significant risk for mortality in COVID-19 infections and is most dramatically noted in critically ill patients. Hyperglycemia and/or diabetes are noted in approximately 30%–40% of patients admitted with COVID-19 infections. Previous studies have shown a marked increase in mortali...

Descripción completa

Detalles Bibliográficos
Autores principales: Valk, Timothy, McMorrow, Carol
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Review Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7686601/
https://www.ncbi.nlm.nih.gov/pubmed/33282306
http://dx.doi.org/10.1177/2050312120974174

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7686601/
https://www.ncbi.nlm.nih.gov/pubmed/33282306
http://dx.doi.org/10.1177/2050312120974174

Ejemplares similares